Rubedo Life Sciences

Rubedo Life Sciences is a clinical-stage biotechnology company discovering and developing precision medicines that target the biological drivers of aging and age-related diseases. Its proprietary ALEMBIC drug-discovery platform identifies and validates senescent ("zombie") cells that accumulate with age and drive chronic disease, enabling the design of selective senolytic therapeutics. The company's lead candidate, RLS-1496, is a first-in-class selective GPX4 modulator that has produced positive Phase 1 dermatology results (plaque psoriasis, atopic dermatitis, skin aging) and Phase 1b/2a data in actinic keratosis. Rubedo is backed by Khosla Ventures and operates as a therapeutics company rather than a software/API provider — this profile carries no developer or API surface.

Rubedo Life Sciences is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Longevity, and Senolytics.

Rubedo Life Sciences’ developer surface includes engineering blog, support, and 2 more developer resources.

🌐 Visit website 📡 Source on GitHub
8.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyPharmaceuticalsLongevitySenolyticsDrug DiscoveryAgingClinical Trials

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 8.1/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 1.3 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/rubedolife: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Rubedolife Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support
Support

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: rubedolife
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/rubedolife.png
name: Rubedo Life Sciences
description: Rubedo Life Sciences is a clinical-stage biotechnology company discovering and developing precision medicines
  that target the biological drivers of aging and age-related diseases. Its proprietary ALEMBIC drug-discovery platform identifies
  and validates senescent ("zombie") cells that accumulate with age and drive chronic disease, enabling the design of selective
  senolytic therapeutics. The company's lead candidate, RLS-1496, is a first-in-class selective GPX4 modulator that has produced
  positive Phase 1 dermatology results (plaque psoriasis, atopic dermatitis, skin aging) and Phase 1b/2a data in actinic keratosis.
  Rubedo is backed by Khosla Ventures and operates as a therapeutics company rather than a software/API provider — this profile
  carries no developer or API surface.
url: https://raw.githubusercontent.com/api-evangelist/rubedolife/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- khosla-ventures
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Longevity
- Senolytics
- Drug Discovery
- Aging
- Clinical Trials
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.rubedolife.com/
- type: Blog
  url: https://www.rubedolife.com/investors-news/
- type: Support
  url: https://www.rubedolife.com/contact-us/
- type: DomainSecurity
  url: security/rubedolife-domain-security.yml
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1